{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-032138","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2023-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.562862+00:00","generated_at":"2026-06-10T22:02:05.486822+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MyMD grants 1M options to President/CMO; salary raised to $500k","bullets":["Options to purchase 1,000,000 shares at $0.81 per share, vesting on clinical milestones over 12 months.","Annual base salary set at $500,000 retroactive to Jan 1, 2023, under amended employment agreement.","Dr. Chapman must devote majority of efforts to the Company.","Options granted under the 2021 Equity Incentive Plan approved by compensation committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-032138","json":"https://secwatch.observer/filing/0001493152-23-032138.json","markdown":"https://secwatch.observer/filing/0001493152-23-032138.md","text":"https://secwatch.observer/filing/0001493152-23-032138.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223032138/0001493152-23-032138-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223032138/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:02:05.486822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}